These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19701096)

  • 1. Intrapericardial delivery of amiodarone and sotalol: atrial transmural drug distribution and electrophysiological effects.
    Bolderman RW; Hermans JJ; Rademakers LM; Jansen TS; Verheule S; van der Veen FH; Maessen JG
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):355-63. PubMed ID: 19701096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.
    van Brakel TJ; Hermans JJ; Accord RE; Schotten U; Smits JF; Allessie MA; Maessen JG
    J Cardiovasc Electrophysiol; 2009 Feb; 20(2):207-15. PubMed ID: 19175851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epicardial application of an amiodarone-releasing hydrogel to suppress atrial tachyarrhythmias.
    Bolderman RW; Hermans JJ; Rademakers LM; de Jong MM; Bruin P; Dias AA; van der Veen FH; Maessen JG
    Int J Cardiol; 2011 Jun; 149(3):341-6. PubMed ID: 20202709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch.
    Bolderman RW; Bruin P; Hermans JJ; Boerakker MJ; Dias AA; van der Veen FH; Maessen JG
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):904-10. PubMed ID: 20363485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
    Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
    Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation.
    Wang W; Mei YQ; Yuan XH; Feng XD
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):80-5. PubMed ID: 26254755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle.
    Moro S; Ferreiro M; Celestino D; Medei E; Elizari MV; Sicouri S
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):314-21. PubMed ID: 18172226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation: first animal trial.
    Beckerman Z; Azran A; Cohen O; Nir RR; Maessen JG; Bianco-Peled H; Bolotin G
    J Cardiovasc Pharmacol Ther; 2014 Sep; 19(5):481-91. PubMed ID: 24742769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapericardial delivery of amiodarone rapidly achieves therapeutic levels in the atrium.
    Marcano J; Campos K; Rodriguez V; Handy K; Brewer MA; Cohn WE
    Heart Surg Forum; 2013 Oct; 16(5):E279-86. PubMed ID: 24364084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K; Whittaker VJ; Sutton A; Campbell P; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration.
    Richardson ES; Rolfes C; Woo OS; Elmquist WF; Benditt DG; Iaizzo PA
    J Cardiovasc Transl Res; 2012 Aug; 5(4):535-40. PubMed ID: 21877256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation.
    Ayers GM; Rho TH; Ben-David J; Besch HR; Zipes DP
    J Cardiovasc Electrophysiol; 1996 Aug; 7(8):713-21. PubMed ID: 8856462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of amiodarone in heart tissues following intrapericardial administration.
    Darsinos JT; Karli JN; Samouilidou EC; Krumbholz B; Pistevos AC; Levis GM
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):301-6. PubMed ID: 10395122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation.
    Feng XD; Wang XN; Yuan XH; Wang W
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):939-43. PubMed ID: 25043862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents.
    Morady F
    Am J Cardiol; 1999 Nov; 84(9A):156R-160R. PubMed ID: 10568676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
    N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.
    Chiba T; Kondo N; Takahara A
    J Pharmacol Sci; 2016 Mar; 130(3):170-6. PubMed ID: 27032905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation.
    Habbab LM; Chu FV
    J Card Surg; 2016 Apr; 31(4):253-8. PubMed ID: 26833498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.